NucleomaxX

DRUG2 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID)

Conditions

HIV InfectionsLipoatrophyLipodystrophyMetabolic DiseasesNutrition Disorders

Phase 2

Effectiveness of Nucleoside Supplementation or Switch to Tenofovir in Reversing Fat Loss in HIV Infected Adults

CompletedNCT00119379

National Institute of Allergy and Infectious Diseases (NIAID)HIV Infections, Lipodystrophy, Metabolic Diseases +1

Start: 2005-04-30End: 2008-10-31Updated: 2017-06-07

Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy

CompletedNCT00307164

National Institute of Allergy and Infectious Diseases (NIAID)HIV Infections, Lipoatrophy

Start: 2006-09-30End: 2008-12-31Updated: 2021-11-04

Related Papers

Mitochondrial function, inflammation, fat and bone in HIV lipoatrophy: randomized study of uridine supplementation or switch to tenofovir.

2011-10-1311 citations